2 results about "High energy proton" patented technology

This invention provides a Dunaliella salina mutant strain DS-HC01, which exhibits both rapid growth and high carotenoid accumulation capabilities, with the preservation number CCTCC NO: M 2026726. The mutant strain was obtained through high-energy proton beam mutagenesis at 300 MeV and a dose of 100 Gy, followed by three-stage screening. Under 25°C culture conditions, DS-HC01 overcomes the trade-off between growth and product accumulation, achieving a cell density more than 1.2 times that of the wild type on day 10, and a total carotenoid content more than 1.25 times higher. It also exhibits higher SOD activity and lower MDA content, demonstrating extremely strong antioxidant regulation capabilities and synergistic advantages in growth and pigment accumulation, making it suitable for efficient fermentation production of carotenoids.

This invention relates to a method for generating a high-purity Ac-225 radioactive beam based on an online isotope separator. A high-energy proton beam with an energy of 100 MeV is generated using a cyclotron accelerator. This high-energy proton beam is transmitted to an ISOL target chamber and bombards a thorium carbide target within the chamber, causing a nuclear reaction. Atoms produced in the nuclear reaction escape from the target and interact with a specific wavelength of incident laser light, resulting in stimulated ionization. The stimulated ionized radioactive nuclear beam is extracted by a high-voltage ion source and then transmitted via a beam transport system to a pre-analytical magnet. The radioactive nuclear beam undergoes preliminary separation by the pre-analytical magnet. After preliminary separation, the radioactive nuclear beam is further accelerated by a high-voltage accelerator tube and then further separated by the main analytical magnet to improve the purity of the beam. Compared with radiochemical separation methods, this invention offers higher separation efficiency and a shorter separation cycle, yielding Ac-225 with a purity exceeding 99%. Further purification is expected to meet the requirements of clinical trial standards.